» Articles » PMID: 27174562

Upregulation of MicroRNA-22 Contributes to Myocardial Ischemia-reperfusion Injury by Interfering with the Mitochondrial Function

Overview
Date 2016 May 14
PMID 27174562
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial oxidative damage is critically involved in cardiac ischemia reperfusion (I/R) injury. MicroRNA-22 (miR-22) has been predicted to potentially target sirtuin-1 (Sirt1) and peroxisome proliferator-activated receptor-γ coactivator-1α (PGC1α), both of which are known to provide protection against mitochondrial oxidative injury. The present study aims to investigate whether miR-22 is involved in the regulation of cardiac I/R injury by regulation of mitochondrial function. We found that miR-22 level was significantly increased in rat hearts subjected to I/R injury, as compared with the sham group. Intra-myocardial injection of 20 ug miR-22 inhibitor reduced I/R injury as evidenced by significant decreases in cardiac infarct size, serum lactate dehydrogenase (LDH) and creatine kinase (CK) levels and the number of apoptotic cardiomyocytes. H9c2 cardiomyocytes exposed to hypoxia/reoxygenation (H/R) insult exhibited an increase in miR-22 expression, which was blocked by reactive oxygen species (ROS) scavenger and p53 inhibitor. In addition, miR-22 inhibitor attenuated, whereas miR-22 mimic aggravated H/R-induced injury in H9c2 cardiomyocytes. MiR-22 inhibitor per se had no significant effect on cardiac mitochondrial function. Mitochondria from rat receiving miR-22 inhibitor 48h before ischemia were found to have a significantly less mitochondrial superoxide production and greater mitochondrial membrane potential and ATP production as compared with rat receiving miR control. In H9c2 cardiomyocyte, it was found that miR-22 mimic aggravated, whilst miR-22 inhibitor significantly attenuated H/R-induced mitochondrial damage. By using real time PCR, western blot and dual-luciferase reporter gene analyses, we identified Sirt1 and PGC1α as miR-22 targets in cardiomyocytes. It was found that silencing of Sirt1 abolished the protective effect of miR-22 inhibitor against H/R-induced mitochondrial dysfunction and cell injury in cardiomyocytes. Taken together, our findings reveal a novel molecular mechanism for cardiac mitochondrial dysfunction during myocardial I/R injury at the miRNA level and demonstrate the therapeutic potential of miR-22 inhibition for acute myocardial I/R injury by maintaining cardiac mitochondrial function.

Citing Articles

The role of sirtuins in the regulation of reactive oxygen species in myocardial ischemia/reperfusion injury.

Wang Z, Zhao X, Lu M, Wang N, Xu S, Min D Mol Cell Biochem. 2025; .

PMID: 39920412 DOI: 10.1007/s11010-024-05204-9.


Evidence and perspectives on miRNA, circRNA, and lncRNA in myocardial ischemia-reperfusion injury: a bibliometric study.

Bo X, Li Q, Chen S, Zhou T, Yin N, Song W J Cardiothorac Surg. 2025; 20(1):66.

PMID: 39815292 PMC: 11736979. DOI: 10.1186/s13019-024-03238-0.


METTL3, m6A modification, and EGR1: interplay affecting myocardial I/R injury outcomes.

Huang C, Zhang X, Wu S, Chang Q, Zheng Z, Xu J Cell Biol Toxicol. 2024; 41(1):7.

PMID: 39707117 PMC: 11662061. DOI: 10.1007/s10565-024-09937-7.


Quercetin Promotes the Repair of Mitochondrial Function in H9c2 Cells Through the miR-92a-3p/Mfn1 Axis.

Li F, Li D, Yan X, Zhu F, Tang S, Liu J Curr Pharm Biotechnol. 2024; 25(14):1858-1866.

PMID: 38173217 DOI: 10.2174/0113892010266863231030052150.


Effects of non-coding RNAs and RNA-binding proteins on mitochondrial dysfunction in diabetic cardiomyopathy.

Potel K, Cornelius V, Yacoub A, Chokr A, Donaghy C, Kelaini S Front Cardiovasc Med. 2023; 10:1165302.

PMID: 37719978 PMC: 10502732. DOI: 10.3389/fcvm.2023.1165302.